Press Releases

Mimetogen Pharmaceuticals Announce the Appointment of David Guyer, M.D., to Board of Directors and Jay Stuart Pepose as Chief Medical Advisor 28 September 2021
Mimetogen pharmaceuticals completes enrollment of mim-728 phase 3 trial for tavilermide for dry eye disease 31 March 2020
  • Home
  • The Company
    • Management
    • Board of Directors
    • Clinical Advisors
  • About Dry Eye
  • Research & Technology
  • Clinical Development
  • News & Publications
    • Press Releases
    • Mimetogen in the News
    • Publications & Presentations

logo mimetogen

CONTACT US:

  

MIMETOGEN CANADA
1000 de La Gauchetière Street West, Suite 2100.
Montréal, Québec, H3B 4W5, Canada

MIMETOGEN USA
67 Batterymarch St., 5th Floor Boston, MA  02110